Form 20-F

External Data Platform from Explorium Now Available on SAP® Store

Thursday, October 21, 2021 - 4:00pm

SAN MATEO, Calif., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Explorium today announced that its External Data Platform is now available on SAP Store , the online marketplace for SAP and partner offerings.

Key Points: 
  • SAN MATEO, Calif., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Explorium today announced that its External Data Platform is now available on SAP Store , the online marketplace for SAP and partner offerings.
  • Exploriums External Data Platform integrates with the SAP Sales Cloud and SAP Customer Data Cloud solutions to help improve sales and marketing efforts for customers.
  • With the Explorium platform, customers can increase revenue, streamline operations, reduce risk and automate external data integration into their modeling pipeline, said Omer Har, Co-founder and Chief Technology Officer of Explorium.
  • Explorium External Data Platform empowers data scientists and analysts to acquire and integrate third-party data efficiently, cost-effectively and in compliance with regulations.

iClick Interactive Asia Group Limited Announces Formation of Special Committee and Engagement of Financial Adviser to Evaluate and Consider Prior Proposals or Any Alternative Strategic Option

Thursday, October 21, 2021 - 2:00pm

The Special Committee has engaged Nomura International (Hong Kong) Limited as its financial advisor to assist in its evaluation.

Key Points: 
  • The Special Committee has engaged Nomura International (Hong Kong) Limited as its financial advisor to assist in its evaluation.
  • The Company does not undertake any obligation to provide any updates with respect to the Prior Proposals or any other transaction, except as required under applicable law.
  • Founded in 2009, iClick Interactive Asia Group Limited (NASDAQ: ICLK) is a leading enterprise and marketing cloud platform in China.
  • Headquartered in Hong Kong, iClick currently operates in eleven locations across Asia and Europe.

BeyondSpring Announces First Patient Treated in Phase 2 Study with Plinabulin Combined with Nivolumab + Ipilimumab in Patients in 3rd Line Recurrent Small-Cell Lung Cancer Patients Who Failed Checkpoint Inhibitors

Thursday, October 21, 2021 - 12:00pm

NEW YORK, Oct. 21, 2021 (GLOBE NEWSWIRE) -- BeyondSpring (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global pharmaceutical company focused on the development of cancer therapeutics, announced the first patient has been treated in an investigator-initiated, open-label Phase 2 study with lead asset plinabulin in combination with nivolumab + ipilimumab in patients with 3rd line recurrent small-cell lung cancer (SCLC) who failed checkpoint inhibitors and platinum-based chemotherapy. Plinabulin is a selective immunomodulating microtubule-binding agent (SIMBA), which is a potent antigen presenting cell (APC) inducer. This Phase 2 study, to be conducted through the Big Ten Cancer Research Consortium in 7 U.S. clinical centers, comes after the successful completion of the Phase 1 dose escalation study portion of this Phase 1/2 study.

Key Points: 
  • In the Phase 1 study, plinabulin combination was able to induce tumor responses in patients who had progressed on platinum and checkpoint inhibitors, with 43% ORR (3 partial responses with tumor reduction >50%).
  • This Phase 2 study, to be conducted through the Big Ten Cancer Research Consortium in 7 U.S. clinical centers, comes after the successful completion of the Phase 1 dose escalation study portion of this Phase 1/2 study.
  • For patients with extensive stage SCLC who failed chemo and checkpoint inhibitors, effective treatment options are limited.
  • In the Phase 1 study, the addition of plinabulin to nivolumab + ipilimumab was able to induce tumor responses in patients who failed chemotherapy and checkpoint inhibitors with ORR at 43%, double the ORR of nivolumab + ipilimumab in Checkmate 032.

Caesarstone Announces Date for Third Quarter 2021 Results

Wednesday, October 20, 2021 - 9:15pm

Caesarstone Ltd. (NASDAQ: CSTE), a leading developer and manufacturer of high-quality engineered surfaces, today announced that it will release its earnings results for the third quarter ended September 30, 2021, on Wednesday, November 3, 2021, before the market opens.

Key Points: 
  • Caesarstone Ltd. (NASDAQ: CSTE), a leading developer and manufacturer of high-quality engineered surfaces, today announced that it will release its earnings results for the third quarter ended September 30, 2021, on Wednesday, November 3, 2021, before the market opens.
  • ET to discuss the results, followed by a question and answer session for the investment community.
  • Upon dialing in, please request to join the Caesarstone Third Quarter 2021 Earnings Conference Call.
  • Actual results may differ materially from those projected as a result of certain risks and uncertainties, both known or unknown.

International Game Technology PLC to Host Third Quarter 2021 Results Conference Call on Tuesday, November 9, 2021

Wednesday, October 20, 2021 - 9:31pm

LONDON, Oct. 20, 2021 /PRNewswire/ --International Game Technology PLC ("IGT") (NYSE:IGT) will host a conference call and live webcast to discuss thirdquarter 2021 results for the period ended September30, 2021 on Tuesday, November 9, 2021.

Key Points: 
  • LONDON, Oct. 20, 2021 /PRNewswire/ --International Game Technology PLC ("IGT") (NYSE:IGT) will host a conference call and live webcast to discuss thirdquarter 2021 results for the period ended September30, 2021 on Tuesday, November 9, 2021.
  • Webcast registration: A live, listen-only webcast is available under "Events Calendar" on IGT's Investor Relations website at www.IGT.com .
  • All subsequent written or oral forward-looking statements attributable to International Game Technology PLC, or persons acting on its behalf, are expressly qualified in their entirety by this cautionary statement.
  • Phil O'Shaughnessy, Global Communications, toll free in U.S./Canada +1 (844) IGT-7452; outside U.S./Canada +1 (401) 392-7452
    View original content to download multimedia: https://www.prnewswire.com/news-releases/international-game-technology-p...

BeyondSpring Pharmaceuticals Announces New Patient-Derived Cancer Model Data for Plinabulin Monotherpy at the AACR-NCI-EORTC Virtual International Conference to Further Support the Positive Clinical Data Already Reported for the Treatment of Small Cell Lu

Wednesday, October 20, 2021 - 12:00pm

The positive PDX preclinical data increases our confidence in pursuing SCLC as an indication for plinabulin, which has shown high response rate data in human studies.

Key Points: 
  • The positive PDX preclinical data increases our confidence in pursuing SCLC as an indication for plinabulin, which has shown high response rate data in human studies.
  • The preclinical data presented here supports our intended strategy for developing an option for cancer patients by combining plinabulin and checkpoint inhibitors in SCLC.
  • Plinabulins anti-cancer effect is supported by the positive Phase 3 DUBLIN-3 non-small cell lung cancer study with evidence of the extension of overall survival.
  • Plinabulin, BeyondSprings lead asset, is a selective immunomodulating microtubule-binding agent (SIMBA), which is a potent antigen presenting cell (APC) inducer.

Perion Launches SORT™, a Moonshot Privacy-First Solution that Proves Cookieless Technology Can Outperform Alternatives

Wednesday, October 20, 2021 - 8:00am

SORT is being initially offered by Undertone , a Perion company and the leader in data-driven, intelligent high impact campaigns.

Key Points: 
  • SORT is being initially offered by Undertone , a Perion company and the leader in data-driven, intelligent high impact campaigns.
  • Advertisers will have the ability to display a SORT Signal to highlight to consumers that they are protecting their privacy.
  • To demonstrate its commitment to independent assessment and analysis, Perion invited Neutronian, a pioneer of independent data quality certification, to review its solution and results.
  • After a comprehensive audit process, Perion has been awarded with Neutronians Cookieless Certification for its SORT technology.

Diana Shipping Inc. Announces Filing of Draft Registration Statement Relating to Proposed Spin-Off of Three Dry Bulk Vessels and Declaration of Cash Dividend

Tuesday, October 19, 2021 - 2:29pm

The Company will also receive preferred shares in OceanPal Inc. that will entitle the Company to certain preferred dividend and voting rights.

Key Points: 
  • The Company will also receive preferred shares in OceanPal Inc. that will entitle the Company to certain preferred dividend and voting rights.
  • The registration statement on Form 20-F includes a more detailed description of the terms of the proposed spin-off transaction.
  • The information in the filed registration statement on Form 20-F is not final and remains subject to change.
  • Diana Shipping Inc. is a global provider of shipping transportation services through its ownership of dry bulk vessels.

Seanergy Maritime Announces Acquisition of its 17th Capesize Vessel with Prompt Delivery and Completion of Previously-Announced Vessel Sale

Tuesday, October 19, 2021 - 2:00pm

About Seanergy Maritime Holdings Corp.

Key Points: 
  • About Seanergy Maritime Holdings Corp.
    Seanergy Maritime Holdings Corp. is the only pure-play Capesize ship-owner publicly listed in the US.
  • Seanergy provides marine dry bulk transportation services through a modern fleet of Capesize vessels.
  • Upon delivery of the M/V Dukeship, the Company's operating fleet will consist of 17 Capesize vessels with an average age of 11.5 years and aggregate cargo carrying capacity of approximately 3,011,083 dwt.
  • The Company is incorporated in the Marshall Islands and has executive offices in Glyfada, Greece.

EY-Nottingham Spirk Innovation Hub opens in Cleveland, Ohio

Tuesday, October 19, 2021 - 1:00pm

NEW YORK, Oct.19, 2021 /PRNewswire/ -- Ernst & Young LLP (EY US) today announced that the EY-Nottingham Spirk Innovation Hub in Cleveland, Ohio, has opened its new facility.

Key Points: 
  • NEW YORK, Oct.19, 2021 /PRNewswire/ -- Ernst & Young LLP (EY US) today announced that the EY-Nottingham Spirk Innovation Hub in Cleveland, Ohio, has opened its new facility.
  • "The Innovation Hub uses the power of our physical and digital capabilities as well as our ecosystem of partners to help our clients solve their biggest challenges and opportunities," said Jerry Gootee, EY Global Advanced Manufacturing Leader.
  • "By bringing together people, software and hardware into a real-world production environment, we can help leaders visualize and experience customer-centric solutions," said John Spirk, Co-president and Co-founder of Nottingham Spirk.
  • To learn how you can experience the Hub and ignite your business growth, visit the EY-Nottingham Spirk Innovation Hub.